155 related articles for article (PubMed ID: 9022579)
1. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study.
Tano S; Ueno N; Tomiyama T; Kimura K
Clin Radiol; 1997 Jan; 52(1):41-5. PubMed ID: 9022579
[TBL] [Abstract][Full Text] [Related]
2. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
[TBL] [Abstract][Full Text] [Related]
3. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
[TBL] [Abstract][Full Text] [Related]
4. Enhanced color flows in hepatic tumors.
Yang CC; Chen CH; Yeh YH
Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
[TBL] [Abstract][Full Text] [Related]
5. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
6. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
7. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
8. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
[TBL] [Abstract][Full Text] [Related]
9. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
Furuse J; Nagase M; Ishii H; Yoshino M
Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
[TBL] [Abstract][Full Text] [Related]
10. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
[TBL] [Abstract][Full Text] [Related]
12. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
[TBL] [Abstract][Full Text] [Related]
13. Correlation between microbubble contrast-enhanced color doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results.
Kitamura H; Kawasaki S; Nakajima K; Ota H
J Clin Ultrasound; 2002 Oct; 30(8):465-71. PubMed ID: 12242734
[TBL] [Abstract][Full Text] [Related]
14. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
Khong PL; Chau MT; Fan ST; Leong LL
Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
[TBL] [Abstract][Full Text] [Related]
17. [Value of combined conventional and contrast enhanced sonography in the evaluation of hepatic disorders].
Tranquart F; Bleuzen A; Kissel A
J Radiol; 2004 Jun; 85(6 Pt 1):755-62. PubMed ID: 15243376
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
19. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report.
Leen E; Angerson WJ; Warren HW; O'Gorman P; Moule B; Carter EC; McArdle CS
Br J Surg; 1994 Feb; 81(2):252-4. PubMed ID: 8156351
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of blood flow signal in small hepatic nodules by color Doppler ultrasonography.
Furuse J; Iwasaki M; Yoshino M; Konishi M; Kawano N; Kinoshita T; Ryu M
Jpn J Clin Oncol; 1996 Oct; 26(5):335-40. PubMed ID: 8895674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
